Stephen J. Schuster, M.D.

faculty photo
Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-178
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 349-5330
Fax: 215-615-5888
Education:
B.S. (Psychology)
Saint Joseph's University, Philadelphia, PA, 1976.

Laboratory Research Technician, Division of Rheumatology, Hahnemann Medical College and Hospital, Philadelphia, PA, 1977.
M.D.
Jefferson Medical College, Philadelphia, PA, 1981.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Mueller, Karen Thudium. Grupp, Stephan A. Maude, Shannon L. Levine, John E. Pulsipher, Michael A. Boyer, Michael W. August, Keith. Myers, G Doug. Tam, Constantine S. Jaeger, Ulrich. Foley, Stephen Ronan. Borchmann, Peter. Schuster, Stephen J. Waller, Edmund K. Awasthi, Rakesh. Potthoff, Bernd. Warren, Andy. Waldron, Edward. McBlane, Fraser. Chassot-Agostinho, Andrea. Laetsch, Theodore W. : Tisagenlecleucel Immunogenicity in Relapsed/Refractory Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma. Blood Advances. Aug 25 2021 Notes: [E-pub ahead of print]

Westin, Jason R. Kersten, Marie José. Salles, Gilles. Abramson, Jeremy S. Schuster, Stephen J. Locke, Frederick L. Andreadis, Charalambos. : Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed/refractory aggressive B-cell lymphomas: Observations from the JULIET, ZUMA-1, and TRANSCEND trials. American Journal of Hematology. Jul 26 2021 Notes: [E-pub ahead of print]

Mato, Anthony R. Ghosh, Nilanjan. Schuster, Stephen J. Lamanna, Nicole. Pagel, John M. Flinn, Ian W. Barrientos, Jacqueline C. Rai, Kanti R. Reeves, James A. Cheson, Bruce D. Barr, Paul M. Kambhampati, Suman. Lansigan, Frederick. Pu, Jeffrey J. Skarbnik, Alan P. Roeker, Lindsey. Fonseca, Gustavo A. Sitlinger, Andrea. Hamadeh, Issam S. Dorsey, Colleen. LaRatta, Nicole. Weissbrot, Hanna. Luning Prak, Eline T. Tsao, Patricia. Paskalis, Dana. Sportelli, Peter. Miskin, Hari P. Weiss, Michael S. Svoboda, Jakub. Brander, Danielle M. : Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy. Blood. 137(20): 2817-2826, May 2021.

Wagner-Johnston, Nina D. Schuster, Stephen J. deVos, Sven. Salles, Gilles. Jurczak, Wojciech J. Flowers, Christopher R. Viardot, Andreas. Flinn, Ian W. Martin, Peter. Xing, Guan. Rajakumaraswamy, Nishanthan. Gopal, Ajay K.: Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas. Leukemia Lymphoma. 62(5): 1077-1087, May 2021.

Sharman, Jeff P. Brander, Danielle M. Mato, Anthony R. Ghosh, Nilanjan. Schuster, Stephen J. Kambhampati, Suman. Burke, John M. Lansigan, Frederick. Schreeder, Marshall T. Lunin, Scott D. Zweibach, Alexander. Shtivelband, Mikhail. Travis, Patrick M. Chandler, Jason C. Kolibaba, Kathryn S. Sportelli, Peter. Miskin, Hari P. Weiss, Michael S. Flinn, Ian W.: Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial. Lancet Haematol. 8(4): e254-e266, Apr 2021.

Mato, Anthony R. Shah, Nirav N. Jurczak, Wojciech. Cheah, Chan Y. Pagel, John M. Woyach, Jennifer. Fakhri, Bita. Eyre, Toby A. Lamanna, Nicole. Patel, Manish R. Alencar, Alvaro. Lech-Maranda, Ewa. Wierda, William G. Coombs, Catherine C. Gerson, James N. Ghia, Paolo. Le Gouill, Steven. Lewis, David John. Sundaram, Suchitra. Cohen, Jonathon B. Flinn, Ian W. Tam, Constantine S. Barve, Minal A. Kuss, Bryone. Taylor, Justin. Abdel-Wahab, Omar. Schuster, Stephen J. Palomba, M Lia. Lewis, Katharine L. Roeker, Lindsey E. Davids, Matthew S. Tan, Xuan Ni. Fenske, Timothy S. Wallin, Johan. Tsai, Donald E. Ku, Nora C. Zhu, Edward. Chen, Jessica. Yin, Ming. Nair, Binoj. Ebata, Kevin. Marella, Narasimha. Brown, Jennifer R. Wang, Michael.: Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study. Lancet. 397(10277): 892-901, Mar 6 2021.

Chong, Elise A. Ruella, Marco. Schuster, Stephen J.: Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy. the New England Journal of Medicine. 384(7): 673-674, Feb 18 2021.

Eyre, Toby A. Lamanna, Nicole. Roeker, Lindsey E. Ujjani, Chaitra S. Hill, Brian T. Barr, Paul M. Lansigan, Erick. Cheson, Bruce D. Yazdy, Maryam. Allan, John N. Rhodes, Joanna. Schuster, Stephen J. Nabhan, Chadi. Skarbnik, Alan. Leslie, Lori. Islam, Prioty. Whitaker, Katherine. Coombs, Catherine C. Tuncer, Hande H. Pagel, John M. Jacobs, Ryan. Winter, Allison M. Bailey, Neil. Sitlinger, Andrea. Schuh, Anna H. Follows, George. Fox, Christopher P. Brander, Danielle M. Shadman, Mazyar. Mato, Anthony R.: Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia. Haematologica. 106(1): 284-287, Jan 1 2021.

Lewis, Daniel J. Haun, Paul L. Samimi, Sara S. Vittorio, Carmela C. Villasenor-Park, Jennifer. Barta, Stefan K. Landsburg, Daniel J. Svoboda, Jakub. Nasta, Sunita D. Schuster, Stephen J. Rook, Alain H. Kim, Ellen J.: Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome. JAMA Dermatology. Dec 2020.

Ghilardi, Guido. Braendstrup, Peter. Chong, Elise A. Schuster, Stephen J. Svoboda, Jakub. Ruella, Marco.: CAR‐T TREK through the lymphoma universe, to boldly go where no other therapy has gone before. British Journal of Haematology. Nov 2020.

back to top
Last updated: 08/27/2021
The Trustees of the University of Pennsylvania